InsiderTrades

Form 4 for GKOS GLAUKOS Corp

Accepted 2023-09-18 00:00:00 ET · period of report 2023-09-14 · accession 0001415889-23-013350 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-09-18 2023-09-14 GKOS Burns Thomas William COB, CEO, Dir A - Grant $0.00 +4,169 54.8K +8% $0
D 2023-09-18 2023-09-14 GKOS Burns Thomas William COB, CEO, Dir A - Grant $0.00 +8,416 44.2K +24% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-09-14 A A 4,169 $0.00 54,785 D — — (F1) Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating and Governance Committee of the Issuer's Board of Directors determined on September 14, 2023 that certain of the operational targets had been achieved. The number of shares of common stock reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets. 50% of the number of shares of common stock reported herein will vest and be delivered in October 2023, and the remaining 50% will vest and be delivered in July 2024. (F2) Includes 47,177 restricted stock units that have not yet vested or been delivered to the Reporting Person.
2 Derivative Stock Option (Right to Buy) 2023-09-14 A A 8,416 $0.00 44,184 D $55.18 · — to 2032-03-24 8,416 Common Stock (F3) Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating & Governance Committee determined on September 14, 2023 that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets. (F4) 50% of the portion of the option reported herein will vest and become exercisable in October 2023, and the remaining 50% will vest and become exercisable in July 2024.